Investment

Pomelo Care Raises $25M in Series A Funding to Transform Maternal and Newborn Healthcare

Pomelo Care, a virtual care startup dedicated to improving maternal and newborn health outcomes, has secured $25M in Series A funding led by Andreessen Horowitz. This investment will fuel Pomelo’s expansion of partnerships with major health plans, including Medicaid managed care organizations, employers, and leading academic medical centers. Pomelo Care closed an $8M seed round co-led by Andreessen Horowitz and First Round…

Canadian Fertility Care Platform Twig Fertility Raises $8M in Series A Financing

Toronto-based Twig Fertility, a fertility care platform, has recently concluded its Series A financing round, securing $8M in funding. The round was led by Rhino Ventures, a venture capital firm specialized in healthcare technology investments. This financial backing marks an important milestone for Twig Fertility, enabling the company to advance its platform, expand services, and provide support to individuals and couples on…

Personalized Nutrition Startup AHARA Launches with $10M+ in Funding

Personalized nutrition platform AHARA has announced its beta launch, bolstered by a $10.25M seed funding round led by Greycroft. Additional investors include Headline, SHAKTI, Dr. Samuel Jampolis, Co-founder Wainwright, and Sandy Sholl. AHARA, co-founded by physician nutritionist Dr. Melina Jampolis and tech entrepreneur Julie Wainwright, uses multiple data inputs to generate individualized nutrition recommendations. These data inputs include genetic, epigenetic, and biomarker…

NEXT Life Sciences Raises $1.55M for Plan A, Its Male Contraceptive

NEXT Life Sciences is set to revolutionize contraception with Plan A, a safe, effective, and reversible birth control method for men. Responding to the growing demand for male contraceptives, NEXT aims to initiate clinical trials by the end of 2023. Plan A utilizes Vasalgel, a proprietary hydrogel acquired by NEXT, to provide a reliable contraceptive solution for men. Instead of permanently cutting…

Gedea Biotech Secures €1.3M to Accelerate the Market Launch of Its Antibiotic-Free Vaginal Infection Treatment

Swedish women’s health company Gedea Biotech has raises €1.3M (14 MSEK) to further develop its pHyph, an innovative antibiotic-free treatment for vaginal infections. Vaginal infections affect over 400 million women annually. The fresh funds will support critical development activities, including ongoing proof-of-concept studies, clinical trials, and exploring the impact of pHyph on the vaginal microbiome. The funding round attracted current and new…

Berlin-based Intimate Care Startup Dr. Vivien Karl Raises €1.5M in Pre-seed Funding

German DTC startup Dr. Vivien Karl, is taking strides towards improving women’s intimate health care, and their efforts have now been bolstered by a successful round of pre-seed funding. The company has secured €1.5M from both existing investors and new ones. Notably, Dieter von Holtzbrinck Ventures (DvH Ventures) joins the funding round as the new lead investor, with Tina Müller, the former…

Amsterdam-based Sextech Startup Quinky Secures €100K from Antler

Quinky, an Amsterdam-based sextech startup, is hoping to establish itself as a beacon for Gen Z by addressing the inadequacies of existing sexual and romantic relationship advice platforms. Geared primarily towards older demographics, most of these platforms leave the tech-savvy Gen Z stranded with unreliable sources of information. Quinky aims to rectify this by stepping into the scene as the “Duolingo of…

Mate Fertility Closes a $5.2M Series A to Make Fertility Care More Accessible

Mate Fertility’s mission is to make high quality fertility treatment affordable, accessible and consistent throughout the United States by finding fertility deserts and upskilling OB/GYN partner providers under REI supervision to practice at the top of their license while providing best in class experience to patients. Only a couple of weeks ago in March we reported on the company’s fundraising and crowdfunding…